The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

Diasorin Company Presentation The LIAISON ® NES is a new molecular platform to address the growing diagnostic decentralization trend that is driving the need for fast and accurate testing in laboratory and near-patient settings.

Another innovative product that will enrich the pipeline is Calprotectin 3.0, a new immunoassay able to provide differential diagnosis between Inflammatory Bowel Disease and Irritable Bowel Syndrome, through novel combined biomarkers and machine

Apr 25, 2024 · Access a live DiaSorin SpA Pipeline Insight and Competitive Landscape, 2023 dashboard for 12 months, with up-to-the-minute insights. Fuel your decision making with real-time deal coverage and media activity.

DiaSorin and its subsidiaries are currently working on the development of 102 products that fall under the In Vitro Diagnostics markets. GlobalData’s report DiaSorin Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development.

diasorin: r&d pipeline 2011 - 2015 system leverage diasorin experience and reputation in ids develop an innovative immunodiagnostic chemiluminescent platform characterized by: · biological matrix currently poorly automated · wide applicability · integrable with molecular diagnostics automated stool testing c. difficilec.

Explore Diasorin, Inc. with its drug pipeline, therapeutic area, technology platform, 6 clinical trials, 3 news, and 13 literature.

Explore DiaSorin Molecular LLC with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 1 news, and 2 literature.

Explore DiaSorin AB with its drug pipeline, therapeutic area, technology platform, 2 literature.

Mar 4, 2024 · Diasorin has received the US Food and Drug Administration’s 510(k) clearance for its LIAISON PLEX platform and the accompanying LIAISON PLEX Respiratory flex assay. The development marks a significant expansion of Diasorin’s offerings …